|
 |
News
- Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers
- New Data Suggest Initial Use of Abbott’s HUMIRA® (adalimumab) May Help Prevent Further Joint Damage For Up To Five Years
- Abbott to Present at 17th Annual Credit Suisse Health Care Conference
Features
|
Next Generation Similac Showcases the Nursery of Tomorrow in Central Park The Similac Next Generation Nursery is an exhibit Abbott Nutrition set up in New York City's Central Park recently to showcase innovative products for new parents and their babies. |
|
Abbott's Commitment to Child Nutrition For more than 100 years, Abbott has been a leader in developing innovative, science-based nutrition solutions that help children develop and grow, and live healthier lives. Learn more about the information and support available to ensure children receive the optimal form of nutrition. |
|
Abbott's Commitment in HIV/AIDS Learn how Abbott is fighting this disease around the world by expanding access to treatment, supporting children affected by the virus, and strengthening health care systems. |
|
"We In The Abbott Family Have An Opportunity To Make a Difference" Abbott and its philanthropic foundation, the Abbott Fund, are working with our humanitarian aid organization partners in providing U.S. $1million in aid in response to the May 12 earthquake in Sichuan Province in China. |
|
XIENCE V™ Wins United States Approval The FDA has approved our XIENCE V drug eluting stent for treatment of coronary artery disease. It will launch in the United States immediately and is expected to become a significant contributor to Abbott’s future performance. |
